← Open Payments lookup

KIMBERLY PENLAND: Open Payments

NPI 1467443036 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$480 in 32 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $336 · 2025 $480

Food & beverage: $480
CompanyPaymentsAmount
ABBVIE INC.11$140
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$68
Bayer Healthcare Pharmaceuticals Inc.2$35
Novo Nordisk Inc2$34
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$34
AstraZeneca Pharmaceuticals LP2$31
GlaxoSmithKline, LLC.2$30
Otsuka America Pharmaceutical, Inc.1$22
Corium, LLC1$17
Exact Sciences Corporation1$15

Products named: CAPLYTA, VRAYLAR, UBRELVY, Kerendia, XIFAXAN, QULIPTA, LINZESS, REXULTI.

Industry payments across IN — which companies pay providers there.